Hovione

Hovione, established in 2015, is a Portugal-based pharmaceutical company specializing in the manufacturing of drug substances for off-patent and new drugs. It focuses on complex drug testing, molecule screening, and particle engineering to accelerate and enhance drug development, particularly in dermatology, ophthalmology, and respiratory fields. Hovione partners with pharmaceutical customers to complete clinical development, regulatory approval, and commercialization, aiming to make treatments faster and more affordable.

Gonçalo Rebelo de Andrade

Managing Director

Peter Villax

Chairman

12 past transactions

ExtremoChem

Acquisition in 2023
ExtremoChem is a chemical synthesis company dedicated to the development and commercialization of innovative small synthetic molecules designed for the stabilization of biological materials facing stress conditions. The company provides a comprehensive range of services, including accelerated stability studies, pH stability assessments, thermal stability assessments, and aggregation analysis. These services are aimed at supporting life science research organizations, as well as the pharmaceutical, biotech, agrochemical, and chemical industries. ExtremoChem's work enables the stabilization of medicines and proteins that are otherwise unstable at room temperature, facilitating their storage and use in various applications.

Delox

Seed Round in 2022
Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.

SolasCure

Series A in 2021
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on advancing treatment options for patients with chronic wounds. Founded in 2017, the company is developing Aurase, a hydrogel designed to enhance wound bed preparation through the application of a recombinant enzyme derived from maggots. This innovative approach aims to facilitate wound debridement, a crucial therapeutic procedure that removes dead, damaged, or infected tissue, thereby accelerating the healing process. By leveraging biomimicry and evidence-based medicine, SolasCure seeks to improve patient outcomes across various healthcare settings.

AdaptTech

Venture Round in 2021
AdaptTech Ltd., established in 2015 and based in Birmingham, UK, is a biomedical company specializing in innovative, smart wearable technologies designed to enhance the lives of individuals with physical limitations, particularly those who have experienced lower limb loss. The company's flagship products include the INSIGHT Scanner, which rapidly creates a 3D model of prosthetic sockets; the INSIGHT Wearable, real-time bio-data tracker between the stump and socket; and the INSIGHT App, providing anytime access to results. AdaptTech aims to empower clinicians with improved socket fitting and monitoring methods, ultimately improving the quality of life for users.

Vaxdyn

Seed Round in 2021
Vaxdyn is a biotechnology company focused on the development of vaccines and immunotherapies aimed at preventing infectious diseases, particularly those caused by antibiotic-resistant pathogens. Utilizing innovative technology, Vaxdyn's vaccines incorporate antigens, immunomodulators, nanoparticles, and monoclonal antibodies to effectively combat bacterial infections. This approach helps healthcare professionals mitigate the public health impact of infections that are resistant to traditional treatments. The company actively engages with its customers through various communication channels, including phone, email, and online applications, to address inquiries related to their vaccine offerings.

CellmAbs

Seed Round in 2019
CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

CellmAbs

Seed Round in 2019
CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

SolasCure

Seed Round in 2018
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on advancing treatment options for patients with chronic wounds. Founded in 2017, the company is developing Aurase, a hydrogel designed to enhance wound bed preparation through the application of a recombinant enzyme derived from maggots. This innovative approach aims to facilitate wound debridement, a crucial therapeutic procedure that removes dead, damaged, or infected tissue, thereby accelerating the healing process. By leveraging biomimicry and evidence-based medicine, SolasCure seeks to improve patient outcomes across various healthcare settings.

Delox

Seed Round in 2018
Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.

AdaptTech

Seed Round in 2016
AdaptTech Ltd., established in 2015 and based in Birmingham, UK, is a biomedical company specializing in innovative, smart wearable technologies designed to enhance the lives of individuals with physical limitations, particularly those who have experienced lower limb loss. The company's flagship products include the INSIGHT Scanner, which rapidly creates a 3D model of prosthetic sockets; the INSIGHT Wearable, real-time bio-data tracker between the stump and socket; and the INSIGHT App, providing anytime access to results. AdaptTech aims to empower clinicians with improved socket fitting and monitoring methods, ultimately improving the quality of life for users.

Anybrain

Seed Round in 2015
Anybrain is an artificial intelligence and data processing firm that specializes in enhancing security and fairness in online gaming and esports. The company has developed an anti-fraud platform that employs machine learning algorithms to provide real-time continuous player identification. By analyzing user interaction patterns through keyboard and mouse movements, the platform operates without the need for external sensors. This technology empowers the entertainment industry by facilitating proactive detection of game fraud and abnormal behaviors, ultimately promoting a safer gaming environment.

Performetric

Seed Round in 2015
Performetric is a real-time monitoring system that allows the management of mental fatigue in a non-invasive way that aims to develop leisure and work context-aware environments that may improve the quality of life, wellness, mental health and individual performance. Moreover, it also aims to support a better management of the employees and their work time. This translates into a positive impact in the organization’s productivity and an increased quality of life and better health of the employees.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.